PE20040953A1 - Heterociclos biciclicos y procedimientos para su preparacion - Google Patents
Heterociclos biciclicos y procedimientos para su preparacionInfo
- Publication number
- PE20040953A1 PE20040953A1 PE2004000166A PE2004000166A PE20040953A1 PE 20040953 A1 PE20040953 A1 PE 20040953A1 PE 2004000166 A PE2004000166 A PE 2004000166A PE 2004000166 A PE2004000166 A PE 2004000166A PE 20040953 A1 PE20040953 A1 PE 20040953A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- heterocycles
- bicycle
- preparation
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A HETEROCICLOS BICICLICOS DE FORMULA I DONDE Ra ES H, ALQUILO C1-C4; Rb ES FENILO, BENCILO, 1-FENILETILO EN LOS CUALES EL NUCLEO FENILO ESTA SUSTITUIDO CON R1 A R3; R1 Y R2 SON H, F, Cl,Br, I, ALQUILO C1-C4, ARILO, HETEROARILO, METILO, ENTRE OTROS; R3 ES H, F, Cl, Br, ENTRE OTROS; Rc ES H, F, Cl, Br, OH, ALQUILOXI C1-C4, METOXI, ENTRE OTROS; X ES METINO SUSTITUIDO CON CIANO Y N; Re Y Rd ES H, ALQUILO C1-C3. UN COMPUESTO PREFERIDO ES 4-[(3-CLORO-4-FLUORO-FENIL)AMINO]-6-{[4-(HOMOMORFOLIN-4-IL)-1-OXO-2-BUTEN-1-IL]AMINO}-7-[(S)-(TETRAHIDROFURAN-3-IL)OXI]-QUINAZOLINA. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS DE FORMULA I PRESENTAN UN EFECTO INHIBIDOR SOBRE LA TIROSINAQUINASA Y SON UTILES PARA EL TRATAMIENTO DE TUMORES, HIPERPLASIA BENIGNA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10307165A DE10307165A1 (de) | 2003-02-20 | 2003-02-20 | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040953A1 true PE20040953A1 (es) | 2005-01-20 |
Family
ID=32797568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2004000166A PE20040953A1 (es) | 2003-02-20 | 2004-02-18 | Heterociclos biciclicos y procedimientos para su preparacion |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1597240B1 (es) |
| JP (1) | JP4468305B2 (es) |
| KR (1) | KR20050103230A (es) |
| CN (1) | CN1751033A (es) |
| AR (1) | AR043249A1 (es) |
| AT (1) | ATE407929T1 (es) |
| AU (1) | AU2004213129A1 (es) |
| BR (1) | BRPI0407709A (es) |
| CA (1) | CA2516426A1 (es) |
| CL (1) | CL2004000284A1 (es) |
| DE (2) | DE10307165A1 (es) |
| ES (1) | ES2314374T3 (es) |
| MX (1) | MXPA05008780A (es) |
| NZ (1) | NZ542402A (es) |
| PE (1) | PE20040953A1 (es) |
| RU (1) | RU2005128826A (es) |
| TW (1) | TW200505912A (es) |
| UY (1) | UY28191A1 (es) |
| WO (1) | WO2004074263A1 (es) |
| ZA (1) | ZA200506121B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA71976C2 (en) | 1999-06-21 | 2005-01-17 | Boehringer Ingelheim Pharma | Bicyclic heterocycles and a medicament based thereon |
| US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
| EP1957468A2 (en) * | 2005-09-06 | 2008-08-20 | T.K. Signal Ltd. | Polyalkylene glycol derivatives of 4 - (phenylamino)quinazolines useful as irreversible inhibitors of epidermal growth factor receptor tyrosine kinase |
| EP1948179A1 (en) * | 2005-11-11 | 2008-07-30 | Boehringer Ingelheim International GmbH | Quinazoline derivatives for the treatment of cancer diseases |
| PT1948180E (pt) | 2005-11-11 | 2013-05-10 | Boehringer Ingelheim Int | Tratamento de combinação de cancro compreendendo inibidores de egfr/her2 |
| JP5241513B2 (ja) | 2006-01-26 | 2013-07-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アミノクロトニルアミノ置換キナゾリン誘導体の合成方法 |
| PT2068880E (pt) | 2006-09-18 | 2012-07-12 | Boehringer Ingelheim Int | Método para tratamento do cancro apresentando mutações no egfr |
| WO2011002523A1 (en) * | 2009-07-02 | 2011-01-06 | Kanionusa Inc. | Phosphorus containing quinazoline compounds and methods of use |
| HUE044629T2 (hu) | 2009-07-06 | 2019-11-28 | Boehringer Ingelheim Int | Eljárás BIBW2992, annak sói, valamint e hatóanyagot tartalmazó szilárd gyógyászati készítmények szárítására |
| CN102020639A (zh) * | 2009-09-14 | 2011-04-20 | 上海恒瑞医药有限公司 | 6-氨基喹唑啉或3-氰基喹啉类衍生物、其制备方法及其在医药上的应用 |
| SI2608792T1 (en) | 2010-08-26 | 2018-02-28 | Boehringer Ingelheim International Gmbh | Methods for the administration of an EGFR inhibitor |
| CN102675287A (zh) * | 2011-03-11 | 2012-09-19 | 江苏恒瑞医药股份有限公司 | (e)-n-[4-[[3-氯-4-(2-吡啶基甲氧基)苯基]氨基]-3-氰基-7-乙氧基-6-喹啉基]-3-[(2r)-1-甲基吡咯烷-2-基]丙-2-烯酰胺的可药用的盐、其制备方法及其在医药上的应用 |
| US8828391B2 (en) | 2011-05-17 | 2014-09-09 | Boehringer Ingelheim International Gmbh | Method for EGFR directed combination treatment of non-small cell lung cancer |
| WO2013135176A1 (zh) * | 2012-03-16 | 2013-09-19 | 苏州迈泰生物技术有限公司 | 氨基喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途 |
| WO2013053206A1 (en) | 2011-10-12 | 2013-04-18 | Teligene Ltd | Quinazoline derivatives as kinases inhibitors and methods of use thereof |
| WO2014118197A1 (en) | 2013-02-01 | 2014-08-07 | Boehringer Ingelheim International Gmbh | Radiolabeled quinazoline derivatives |
| US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
| US10710968B2 (en) | 2016-01-13 | 2020-07-14 | Hadasit Medical Research Services And Development Ltd. | Radiolabeled erlotinib analogs and uses thereof |
| TWI808958B (zh) | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
| WO2021209039A1 (zh) * | 2020-04-17 | 2021-10-21 | 北京赛特明强医药科技有限公司 | 一种喹唑啉类化合物、制备方法及其应用 |
| CN115806548A (zh) * | 2021-09-15 | 2023-03-17 | 甫康（上海）健康科技有限责任公司 | 含有egfr抑制剂的药物组合物及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19911509A1 (de) * | 1999-03-15 | 2000-09-21 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE10042060A1 (de) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE10063435A1 (de) * | 2000-12-20 | 2002-07-04 | Boehringer Ingelheim Pharma | Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
-
2003
- 2003-02-20 DE DE10307165A patent/DE10307165A1/de not_active Withdrawn
-
2004
- 2004-02-14 DE DE502004008024T patent/DE502004008024D1/de not_active Expired - Lifetime
- 2004-02-14 BR BRPI0407709-1A patent/BRPI0407709A/pt not_active IP Right Cessation
- 2004-02-14 AT AT04711303T patent/ATE407929T1/de active
- 2004-02-14 RU RU2005128826/04A patent/RU2005128826A/ru not_active Application Discontinuation
- 2004-02-14 WO PCT/EP2004/001398 patent/WO2004074263A1/de active IP Right Grant
- 2004-02-14 MX MXPA05008780A patent/MXPA05008780A/es not_active Application Discontinuation
- 2004-02-14 CA CA002516426A patent/CA2516426A1/en not_active Abandoned
- 2004-02-14 AU AU2004213129A patent/AU2004213129A1/en not_active Abandoned
- 2004-02-14 ES ES04711303T patent/ES2314374T3/es not_active Expired - Lifetime
- 2004-02-14 CN CNA2004800047746A patent/CN1751033A/zh active Pending
- 2004-02-14 KR KR1020057015218A patent/KR20050103230A/ko not_active Application Discontinuation
- 2004-02-14 JP JP2005518423A patent/JP4468305B2/ja not_active Expired - Fee Related
- 2004-02-14 EP EP04711303A patent/EP1597240B1/de not_active Expired - Lifetime
- 2004-02-14 NZ NZ542402A patent/NZ542402A/en unknown
- 2004-02-18 TW TW093103966A patent/TW200505912A/zh unknown
- 2004-02-18 PE PE2004000166A patent/PE20040953A1/es not_active Application Discontinuation
- 2004-02-18 UY UY28191A patent/UY28191A1/es not_active Application Discontinuation
- 2004-02-18 CL CL200400284A patent/CL2004000284A1/es unknown
- 2004-02-20 AR ARP040100540A patent/AR043249A1/es unknown
-
2005
- 2005-08-01 ZA ZA200506121A patent/ZA200506121B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE502004008024D1 (de) | 2008-10-23 |
| DE10307165A1 (de) | 2004-09-02 |
| RU2005128826A (ru) | 2006-08-27 |
| TW200505912A (en) | 2005-02-16 |
| UY28191A1 (es) | 2004-09-30 |
| ZA200506121B (en) | 2006-11-29 |
| JP4468305B2 (ja) | 2010-05-26 |
| MXPA05008780A (es) | 2005-10-18 |
| CL2004000284A1 (es) | 2005-01-14 |
| JP2006515005A (ja) | 2006-05-18 |
| EP1597240B1 (de) | 2008-09-10 |
| NZ542402A (en) | 2008-09-26 |
| KR20050103230A (ko) | 2005-10-27 |
| CA2516426A1 (en) | 2004-09-02 |
| CN1751033A (zh) | 2006-03-22 |
| ES2314374T3 (es) | 2009-03-16 |
| AU2004213129A1 (en) | 2004-09-02 |
| AR043249A1 (es) | 2005-07-20 |
| WO2004074263A1 (de) | 2004-09-02 |
| EP1597240A1 (de) | 2005-11-23 |
| ATE407929T1 (de) | 2008-09-15 |
| BRPI0407709A (pt) | 2006-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040953A1 (es) | Heterociclos biciclicos y procedimientos para su preparacion | |
| PE20040169A1 (es) | Derivados de quinazolin-4-amina como inhibidores de la transduccion de senal inducida por tirosinquinasas | |
| ES2528451T3 (es) | Inhibidores de esfingosina cinasa | |
| PE20020915A1 (es) | Diaminotiazoles como inhibidores de quinasas dependientes de ciclina | |
| AR047538A1 (es) | Piridazinonas como antagonistas de las integrinas alfa4 | |
| PE20060531A1 (es) | Derivados de piridazin-3-(2h)-ona como inhibidores de la fosfodiesterasa 4 | |
| AR041739A1 (es) | Compuestos derivados -3,4-dihidro-1h-pirimido[4,5-d]pirimidin-2-ona y con actividad antiproliferativa. | |
| AR079131A1 (es) | Derivados de naftiridina y el uso de los mismos como inhibidores de quinasa | |
| PE20091384A1 (es) | Compuestos tienopirimidina y pirazolopirimidina como inhibidores de quinasa mtor y quinasa p13 | |
| ATE199553T1 (de) | Pyrrolo(2,3-d)pyrimidinderivate und ihre verwendung | |
| PE20060775A1 (es) | Derivados de pirrolidilo de compuestos heteroaromaticos como inhibidores de fosfodiesterasa | |
| CO4770975A1 (es) | Derivados de quinazolina sustituidos | |
| RU2008102993A (ru) | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| CO6230980A2 (es) | Agentes antihipertensivos de aril-imidasol de accion doble y composiciones farmaeuticas que los contienen | |
| PE20040590A1 (es) | Composiciones de pirrolotriazina anilina como inhibidores de cinasa | |
| AR051767A1 (es) | Derivados de quinolina e isoquinolina 5-sustituidos un procedimiento para su preparacion y su uso como inhibidores de la inflamacion | |
| PE20040512A1 (es) | Compuesto de pirazol-pirimidina anilina | |
| DE60318030D1 (de) | Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose | |
| PE20050896A1 (es) | Intermediarios de quinolina como inhibidores de tirosina quinasas de receptores y la sintesis de los mismos | |
| AR038341A1 (es) | Compuestos que son agonistas de receptores alfa-1 preferentemente agonistas de receptores alfa-1a/l | |
| PE20000230A1 (es) | Compuestos heterociclicos inhibidores de tirosin cinasa | |
| PE20070181A1 (es) | DERIVADOS DE CICLOHEXILAMINISOQUINOLONA COMO INHIBIDORES DE Rho-QUINASA | |
| PE20080841A1 (es) | Derivados de quinazolinona e isoquinolinona y su uso para el tratamiento o prevencion de trastornos relacionados con el estres o la depresion | |
| PE20060600A1 (es) | Derivados de aminopiridina como inhibidores selectivos de la aurora a quinasa | |
| RU2008136784A (ru) | Пиразолохинолоновые соединения, фармацевтическая композиция на их основе, способ ингибирования поли(адф-рибоза)полимеразы (parp) и способы лечения воспаления, сепсиса, септического шока и рака |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |